BACKGROUND: Novel three-layered (TL) tablet systems were compared with both monolithic matrix (MM) formulations and a commercial immediate-release (IR) capsule to develop once-a-day (OAD) pregabalin tablets. METHODS: The physical properties of the TL tablets, including dissolution and swelling rates, were compared with those of the MM tablets and the pharmacokinetic parameters of the TL tablet were compared with those of an IR capsule in beagles and humans. RESULTS: Our results indicated that the same amount of a hydrophilic polymer in the formulations had similar dissolution profiles at 12 h, regardless of the tablet geometry. However, the degree of tablet swelling differed, with larger amounts of polymer in the tablets showing a greater degree of swelling. In addition, TL tablets swelled more rapidly compared with MM tablets. For the pharmacokinetic study of the TL tablet, the beagles demonstrated absorption results similar to those of an IR capsule, whereas the humans demonstrated low total absorption compared with an IR capsule. The time of the peak plasma concentration at 6 h in the fed state of humans coincided with the results of the study on beagles. CONCLUSION: The novel TL tablet system of pregabalin may prove to be helpful in developing improved formulations with better continuous drug absorption for OAD administration.
BACKGROUND: Novel three-layered (TL) tablet systems were compared with both monolithic matrix (MM) formulations and a commercial immediate-release (IR) capsule to develop once-a-day (OAD) pregabalin tablets. METHODS: The physical properties of the TL tablets, including dissolution and swelling rates, were compared with those of the MM tablets and the pharmacokinetic parameters of the TL tablet were compared with those of an IR capsule in beagles and humans. RESULTS: Our results indicated that the same amount of a hydrophilic polymer in the formulations had similar dissolution profiles at 12 h, regardless of the tablet geometry. However, the degree of tablet swelling differed, with larger amounts of polymer in the tablets showing a greater degree of swelling. In addition, TL tablets swelled more rapidly compared with MM tablets. For the pharmacokinetic study of the TL tablet, the beagles demonstrated absorption results similar to those of an IR capsule, whereas the humans demonstrated low total absorption compared with an IR capsule. The time of the peak plasma concentration at 6 h in the fed state of humans coincided with the results of the study on beagles. CONCLUSION: The novel TL tablet system of pregabalin may prove to be helpful in developing improved formulations with better continuous drug absorption for OAD administration.
Authors: Jun Sang Park; Ji Yeon Shim; Jung Soo Park; Young Wook Choi; Seong Hoon Jeong Journal: Drug Dev Ind Pharm Date: 2011-03-30 Impact factor: 3.225
Authors: Howard N Bockbrader; David Wesche; Raymond Miller; Sunny Chapel; Nancy Janiczek; Paula Burger Journal: Clin Pharmacokinet Date: 2010-10 Impact factor: 6.447
Authors: Craig I Coleman; Brendan Limone; Diana M Sobieraj; Soyon Lee; Matthew S Roberts; Rajbir Kaur; Tawfikul Alam Journal: J Manag Care Pharm Date: 2012-09
Authors: Walaa F Alsanie; Majid Alhomrani; Ahmed Gaber; Hamza Habeeballah; Heba A Alkhatabi; Raed I Felimban; Sherin Abdelrahman; Charlotte A E Hauser; Adeel G Chaudhary; Abdulhakeem S Alamri; Bassem M Raafat; Abdulwahab Alamri; Sirajudheen Anwar; Khaled A Alswat; Yusuf S Althobaiti; Yousif A Asiri Journal: Cells Date: 2022-03-01 Impact factor: 6.600